Omega Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €2.67M +49.3% -€84.08M -5.1% -3,148.9% +18 pp -€76.50M -8.7% -2,864.9% +18 pp
    €1.79M +1,339.6% -€88.58M +48.4% -4,951.1% +430 pp -€83.83M +73.0% -4,685.7% +340 pp
    €124.28K +∞% -€59.69M +129.0% -48,029.2% -480 pp -€48.45M +130.8% -38,987.5% -390 pp
    €0.00 +NaN% -€26.06M +63.0% N/A -€20.99M +64.4% N/A
    €0.00 -€15.99M N/A -€12.77M N/A

    Notifications